BRIT J HAEMATOL 2020 10.1111/bjh.16711
Pharmacokinetic and pharmacodynamic effects of ravulizumab and eculizumab on complement component 5 in adults with paroxysmal nocturnal haemoglobinuria: results of two phase 3 randomised, multicentre studies
de Latour1, RP; Brodsky, RA; Ortiz, S; Risitano, AM; Jang, JH; Hillmen, P; Kulagin, AD; Kulasekararaj, AG; Rottinghaus, ST; Aguzzi, R; Gao, X; Wells, RA; Szer, J

ANTIMICROB AGENTS CH 2020 10.1128/AAC.02467-19
Phase 2 Study of Anti-Human Cytomegalovirus Monoclonal Antibodies for Prophylaxis in Hematopoietic Cell Transplantation
Maertens1, J; Logan, AC; Jang, J; Long, G; Tang, JL; Hwang, WYK; Koh, LP; Chemaly, R; Gerbitz, A; Winkler, J; Yeh, SP; Hiemenz, J; Christoph, S; Lee, DG; Wang, PN; Holler, E; Mielke, S; Akard, L; Yeo, A; Ramachandra, S; Smith, K; Pertel, P; Segal, F

ANN LAB MED 2020 10.3343/alm.2020.40.1.88
Relationship of Circulating Cytomegalovirus Levels Obtained Through Antigenemia Testing and Quantitative PCR Differs Between Children and Adults
Choi1, S; Kim, YJ; Yoo, KH; Sung, KW; Koo, HH; Kim, SJ; Jang, JH; Kim, K; Jung, CW; Huh, HJ; Kang, ES

MOL BIOL REP 2019 10.1007/s11033-019-05019-8
Anti-leukemic effects of simvastatin on NRAS(G12D) mutant acute myeloid leukemia cells
Jang1, J; Lee, J; Jang, JH; Jung, CW; Park, S

Lancet Haematol 2019 10.1016/S2352-3026(19)30153-X
Romiplostim in patients with refractory aplastic anaemia previously treated with immunosuppressive therapy: a dose-finding and long-term treatment phase 2 trial
Lee1, JW; Lee, SE; Jung, CW; Park, S; Keta, H; Park, SK; Kim, JA; Oh, IH; Jang, JH

ANN HEMATOL 2019 10.1007/s00277-019-03735-6
Clinical implication of renal dysfunction during the clinical course in patients with paroxysmal nocturnal hemoglobinuria: a longitudinal analysis
Kim1, JS; Cheong, JW; Mun, YC; Jang, JH; Jo, DY; Lee, JW

INT J HEMATOL 2019 10.1007/s12185-019-02699-7
Comparative study on baseline clinical characteristics of Asian versus non-Asian patients with paroxysmal nocturnal hemoglobinuria
Sakurai1, M; Jang, JH; Chou, WC; Kim, JS; Wilson, A; Nishimura, J; Chiou, TJ; Kanakura, Y; Lee, JW; Okamoto, S

BRIT J HAEMATOL 2019 10.1111/bjh.16055
Prospective randomized trial comparing two doses of rabbit anti-thymocyte globulin in patients with severe aplastic anaemia
Narita1, A; Zhu, XF; Muramatsu, H; Chen, XJ; Guo, Y; Yang, WY; Zhang, JL; Liu, F; Jang, JH; Kook, H; Kim, H; Usuki, K; Yamazaki, H; Takahashi, Y; Nakao, S; Lee, JW; Kojima, S

CLIN LYMPHOMA MYELOMA LEUK 2019 10.1016/j.clml.2019.06.003
Clinical Outcomes of Decitabine Treatment for Patients With Lower-Risk Myelodysplastic Syndrome on the Basis of the International Prognostic Scoring System
Jung1, KS; Kim, YJ; Kim, YK; Park, SK; Kim, HG; Kim, SJ; Park, J; Choi, CW; Do, YR; Kim, I; Park, S; Mun, YC; Jeong, SH; Kim, MK; Yi, HG; Chang, MH; Kim, SY; Lee, JH; Jang, JH

ANN HEMATOL 2019 10.1007/s00277-019-03624-y
Different prognostic effects of core-binding factor positive AML with Korean AML registry data
Shin1, HJ; Min, WS; Min, YH; Cheong, JW; Lee, JH; Kim, IH; Hong, DS; Ahn, JS; Kim, HJ; Lee, WS; Jung, CW; Jang, JH; Park, Y; Kim, HJ

Lancet Haematol 2019 10.1016/S2352-3026(18)30231-X
Eltrombopag treatment during induction chemotherapy for acute myeloid leukaemia: a randomised, double-blind, phase 2 study
Frey1, N; Jang, JH; Szer, J; Illes, A; Kim, HJ; Ram, R; Chong, BH; Rowe, JM; Borisenkova, E; Liesveld, J; Winer, ES; Cherfi, A; Aslanis, V; Ghaznawi, F; Strickland, S

ANN HEMATOL 2019 10.1007/s00277-018-3550-z
Utility of allogeneic hematopoietic stem cell transplantation using international donors in a homogenous ethnic population: question in the era of various alternative donors
Kim1, SA; Lee, J; Moon, JH; Lee, H; Jang, J; Cheong, JW; Youk, J; Choi, Y; Kang, M; Shin, M; Koh, Y; Shin, S

AM J HEMATOL 2019 10.1002/ajh.25334
Effectiveness of eculizumab in patients with paroxysmal nocturnal hemoglobinuria (PNH) with or without aplastic anemia in the International PNH Registry
Lee1, JW; de Latour, RP; Brodsky, RA; Jang, JH; Hill, A; Roth, A; Schrezenmeier, H; Wilson, A; Marantz, JL; Maciejewski, JP

ANN LAB MED 2018 10.3343/alm.2018.38.6.495
Poor Prognostic Implication of ASXL1 Mutations in Korean Patients With Chronic Myelomonocytic Leukemia
Kim1, HY; Lee, KO; Park, S; Jang, JH; Jung, CW; Kim, SH; Kim, HJ

BONE MARROW TRANSPL 2018 10.1038/s41409-018-0097-5
Satisfaction with sexual activity and sexual dysfunction in hematopoietic stem cell transplantation survivors and their partners: a couple study
Yoo1, KH; Kang, D; Kim, IR; Choi, EK; Kim, JS; Yoon, SS; Lee, CH; Park, S; Kim, SJ; Kim, K; Kim, WS; Jung, CW; Choi, HJ; Jang, JH; Cho, J
외 다수